Navigation Links
John Theurer Cancer Center hosts hematologic malignancies program for physicians and patients
Date:4/19/2010

HACKENSACK, N.J., (April 12, 2010) John Theurer Cancer Center at Hackensack University Medical Center will host a hematological malignancies conference for physicians and patients on Friday, April 23 and Saturday, April 24. The event, entitled "Current and Innovative Modalities in the Management of Hematological Malignancies", is part of John Theurer Cancer Center's commitment to provide both healthcare professionals as well as patients with an update on the newest advances in the field of blood-borne cancers.

Hematologic malignancies include lymphoma, multiple myeloma, and leukemia, and affect an estimated 140,000 patients a year in the United States. This number represents approximately 10 percent of all new cancer diagnoses. The incidence of these cancers has been steadily rising, up nearly 20 percent in the last six years alone.

All-Day Symposium for Physicians: Friday, April 23

On April 23rd, the John Theurer Cancer Center will bring oncology experts from leading cancer institutions, including the Mayo Clinic, Rochester, Dana Farber Cancer Center Institute in Boston, Fred Hutchinson Cancer Research Center in Seattle, Memorial Sloan Kettering Cancer Center, University of Nebraska Medical Center in Omaha and Robert H. Lurie Comprehensive Cancer Center in Chicago as well as experts from Germany, to discuss important trends in blood-borne cancers to enhance patient care and to incorporate novel therapies through clinical trials. Registration and food are complimentary, and attendees can receive up to 6.5 continuing medical education (CME) credits.

"John Theurer Cancer Center strives to provide the best continuing education programs so that we can further advance cancer treatments and tackle the most complicated cases," Andrew Pecora, M.D., F.A.C.P., C.P.E., Chairman and Executive Administrative Director, John Theurer Cancer Center. "We are proud to bring high-caliber medical leaders to share their expertise with our doctors and healthcare professionals, as well as with the greater medical community."

Key topics of this CME conference include: an update on the management of the main types of lymphomas as well as multiple myeloma; recognizing new prognostic markers in lymphoma including the impact of PET scan imaging; incorporating emerging molecular stratification of both lymphoid and myeloid malignancies; and new trends in autologous and allogenic stem cell transplantation.

Featured Speakers:

  • Ken Anderson, M.D. Dana-Farber Cancer Institute, Professor, Department of Medical Oncology/Hematologic Neoplasia
  • Frederick R. Appelbaum, M.D.Director, Clinical Research Division, Fred Hutchinson Cancer Research Center
  • James Armitage, M.D.University of Nebraska Medical Center, Professor, Section of Hematology & Oncology
  • Thomas E. Witzig, M.D.Mayo Clinic, Professor, Departments of Hematology and Laboratory Medicine and Pathology
  • Volker Diehl, M.D.University of Cologne, German Hodgkin Study Group
  • Steven Rosen, M.D.Robert H. Lurie Comprehensive Cancer Center, Genevieve Teuton Professor of Medicine
  • Martin Tallman, M.D.Upcoming Chief of Leukemia Service at Memorial Sloan Kettering Cancer Center , NY
  • Kip Piper, M.A., F.A.C.H.E.President, Health Results Group, LLC

This CME conference is directed primarily for medical oncologists and hematologists, as well as nurses and other healthcare professionals in the oncology field who are interested in the treatment of hematological malignancies. The conference will be held from 7:00 am to 4:30 pm. Online registration for the CME conference is available at: humccancer.org/CMEConference.

Patient Education Program: Saturday, April 24

The John Theurer Cancer Center's patient education program will bring together patients, families, oncologists and other health care professionals to participate in an open dialogue about specific cancers, including leukemia, lymphoma, and multiple myeloma, as well as bone marrow transplantation.

Oncologists representing each of these divisions within the John Theurer Cancer Center will engage in roundtable discussions exploring treatment options, diagnoses, and clinical trials. Cancer support groups including the Leukemia & Lymphoma Society and Multiple Myeloma Research Foundation will be present as well to provide information to patients and their families.

"We understand that navigating through the maze of cancer decisions can be overwhelming and frightening for many patients and caregivers," said Andre Goy, M.D., Deputy Director, Chief, Division of Lymphoma and Director, Cancer Research, John Theurer Cancer Center. "This gives us a chance to help our patients and their loved ones understand more about the newest trends in care and what their options are."

This event will also feature Candace Sue, a sarcoma survivor, as the keynote speaker. Diagnosed with sarcoma, an often fatal form of cancer, Sue underwent six cycles of chemotherapy and is now cancer free. She has been a Sarcoma Foundation of America Board Member since 2004 and is the Communications Chairperson and a Gala Benefit Committee Member. In her Board role, she championed new branding for the organization, updated its mission and vision, and helped establish the annual patient education conference. Candace also works in Worldwide Communications at Pfizer and is responsible for global, enterprise-wide communications. She holds an MBA from Columbia Business School and an undergraduate degree from Boston University. She is also a Reiki Master with the Center of Living Light in New York.

This patient education day program will be held from 8:00 am to 1:00 pm. Both the patient and physician program will be hosted in the Hekemian Conference Center Auditorium located at Hackensack University Medical Center, 30 Prospect Ave., Hackensack, New Jersey. For more information or to register, you can also contact Jessie Vicioso at 201-996-5931 or rvicioso@humed.com.


'/>"/>

Contact: Amy Leahing
amy.leahing@widmeyer.com
646-213-7245
John Theurer Cancer Center
Source:Eurekalert

Related medicine news :

1. Researchers at the John Theurer Cancer Center Present Cutting-Edge Research Results at this Years American Society of Hematology Annual Meeting
2. Targeted therapy prolongs life in patients with HER2-positive breast cancer
3. New Drugs, New Combinations Fight Breast Cancer
4. Study Finds Possible Explanation for the Link Between Infertility and Breast/Ovarian Cancer Risks
5. MDS Nordions TheraSphere(R) for Unresectable Liver Cancer (HCC) Now Covered by Two Large U.S. Insurers
6. National Oncologist Group Warns: Current Health Care Reform Legislation Woefully Short In Addressing Cancer Care Crisis
7. Panel calls for reducing colorectal cancer deaths by striking down barriers to screening
8. Lung Cancer: Large Impact, Little Funding
9. Inflammation marker related to obesity is elevated in patients with pancreatic cancer
10. Prolactin blocks oncogene associated with poor prognosis in breast cancer
11. Older female cancer survivors have added health issues compared to their counterparts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Apple ... care services, staged a mock evacuation of the facility as part of a disaster ... Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as the ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Global Healthcare Management’s ... Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s ... The fun run is geared towards children of all ages; it is a ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and ... plans to open a flagship location in Covington, LA at 401 N. U.S. Highway ... store next to Office Depot in the Holiday Square shopping center. Its location allows ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... -- NDS received FDA 510(k) clearance in May 2017 for its highly ... designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... support the improvement of patient outcomes, procedural efficiency, and the lowering ... ... ...
(Date:10/4/2017)... 4, 2017  South Korean-based healthcare product Development Company ... "cprCUBE" on Kickstarter. The device will educate the user ... with better efficiency compared to the dated and pricey ... on efficacy of the compression for a more informed ... goal to raise $5,000. ...
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
Breaking Medicine Technology: